Rici Healthcare Holdings Limited

HKEX:1526.HK

1.18 (HKD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q22021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 1,231.2051,708.3491,284.34804.538999.5331,341.93583.261,023.273702.933827.686546.25644.268435.881545.333390.05501.423301.373200.699149.438149.438149.438149.438122.23122.23122.23122.23
Cost of Revenue 834.918942.873800.307642.582726.927803.233541.293689.98552.244544.491443.242374.643304.352302.706278.546283.069239.684130.688102.202102.202102.202102.20280.98180.98180.98180.981
Gross Profit 396.287765.476484.033161.956272.606538.69741.967333.293150.689283.195103.008269.625131.529242.627111.504218.35461.68970.01147.23647.23647.23647.23641.24941.24941.24941.249
Gross Profit Ratio 0.3220.4480.3770.2010.2730.4010.0720.3260.2140.3420.1890.4180.3020.4450.2860.4350.2050.3490.3160.3160.3160.3160.3370.3370.3370.337
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 111.793123.452100.39397.352112.568173.385120.769164.668140.781183.214145.703187.129105.589123.73276.94474.02177.50737.90729.22129.22129.22129.22117.72417.72417.72417.724
Selling & Marketing Expenses 108.614217.395163.189115.6388.452156.06370.256150.86386.712136.04388.971109.37265.95246.07830.27240.41527.19816.90310.62710.62710.62710.6276.9926.9926.9926.992
SG&A 218.536347.509265.956213.763205.325328.108191.025315.531227.493319.257234.674296.601171.541169.91107.216114.486104.75554.8139.84739.84739.84739.84724.71524.71524.71524.715
Other Expenses -7.946-10.417000000000000000-3.127-1.371-1.371-1.371-1.371-1.331-1.331-1.331-1.331
Operating Expenses 210.59337.092245.297200.902199.82340.532189.817294.266210.602298.723233.467312.933178.261139.731103.792104.016104.40651.68438.47638.47638.47638.47623.38423.38423.38423.384
Operating Income 185.697428.384227.649-46.91476.548215.334-138.97630.673-72.571-27.099-128.153-24.458-32.43282.6088.383115.548-41.77717.9838.6998.6998.6998.69917.10117.10117.10117.101
Operating Income Ratio 0.1510.2510.177-0.0580.0770.16-0.2380.03-0.103-0.033-0.235-0.038-0.0740.1510.0210.23-0.1390.090.0580.0580.0580.0580.140.140.140.14
Total Other Income Expenses Net -60.549-62.689-47.712-48.267-80.938-113.426-71.177-68.565-69.685-2.524-8.656-29.115-22.90910.636-10.645-9.837-14.347-5.586-7.215-7.215-7.215-7.215-4.894-4.894-4.894-4.894
Income Before Tax 125.148365.695179.937-95.181-4.39116.453-225.276-37.892-130.356-33.494-142.253-53.573-55.34193.244-2.262105.711-56.12412.3971.4831.4831.4831.48312.20712.20712.20712.207
Income Before Tax Ratio 0.1020.2140.14-0.118-0.0040.087-0.386-0.037-0.185-0.04-0.26-0.083-0.1270.171-0.0060.211-0.1860.0620.010.010.010.010.10.10.10.1
Income Tax Expense 38.02789.93953.71820.73725.66841.26324.93715.48513.23510.17929.2912.1414.09326.6969.89728.8488.3775.1180.0660.0660.0660.0662.2442.2442.2442.244
Net Income 84.991240.433123.37-23.74510.46156.221-164.097-8.922-60.24114.044-67.88-22.726-39.4469.726-10.80276.011-47.0297.2791.4171.4171.4171.4179.9649.9649.9649.964
Net Income Ratio 0.0690.1410.096-0.030.010.116-0.281-0.009-0.0860.017-0.124-0.035-0.090.128-0.0280.152-0.1560.0360.0090.0090.0090.0090.0820.0820.0820.082
EPS 0.0530.150.078-0.0150.0070.098-0.1-0.006-0.0380.006-0.043-0.02-0.0250.045-0.0090.054-0.0390.0050.0010.0010.0010.0010.0060.0060.0060.006
EPS Diluted 0.0530.150.078-0.0150.0070.098-0.1-0.006-0.0380.009-0.043-0.014-0.0240.048-0.0090.057-0.0390.0050.0010.0010.0010.0010.0060.0060.0060.006
EBITDA 281.389519.169310.81443.538159.991296.752-62.003111.037-2.82434.207-67.34917.5126.707122.73248.306153.506-11.81835.19821.45221.45221.45221.45228.86228.86228.86228.862
EBITDA Ratio 0.2290.3040.2420.0540.160.221-0.1060.109-0.0040.041-0.1230.0270.0150.2250.1240.306-0.0390.1750.1440.1440.1440.1440.2360.2360.2360.236